Naoichi Sato

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Kohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki et al. · The Lancet Diabetes & Endocrinology · 2017 · 300 citations

Non-pharmacological Intervention, Diabetes Management, Cardiovascular Disease +9

The dual function of hepatic SOCS3 in insulin resistance <i>in vivo</i>

Takehiro Torisu, Naoichi Sato, Daigo Yoshiga et al. · Genes to Cells · 2007 · 106 citations · Full text

Adenovirus-Mediated High Expression of Resistin Causes Dyslipidemia in Mice

Naoichi Sato, Kunihisa Kobayashi, Toyoshi Inoguchi et al. · Endocrinology · 2004 · 80 citations

Insulin Signaling, Oxidative Stress, Drug Resistance +19

Statin attenuates high glucose-induced and diabetes-induced oxidative stress in vitro and in vivo evaluated by electron spin resonance measurement

Hirotaka Tsubouchi, Toyoshi Inoguchi, Toshiyo Sonta et al. · Free Radical Biology and Medicine · 2005 · 62 citations

Metabolic Syndrome, Oxysterol, Biochemistry +10

Adaptor Protein SH2-B Linking Receptor-Tyrosine Kinase and Akt Promotes Adipocyte Differentiation by Regulating Peroxisome Proliferator-Activated Receptor γ Messenger Ribonucleic Acid Levels

Daigo Yoshiga, Naoichi Sato, Takehiro Torisu et al. · Molecular Endocrinology · 2007 · 31 citations · Full text